The 7th lung cancer TNM classification and staging system: Review of the changes and implications.
about
The International Association for the Study of Lung Cancer Lymph Node Map: A Radiologic Atlas and ReviewPrognostic significance of volume-based PET parameters in cancer patients.From Bench to Bedside: Attempt to Evaluate Repositioning of Drugs in the Treatment of Metastatic Small Cell Lung Cancer (SCLC)Ceritinib: A primer for pharmacists.Correlation of Hsp70 Serum Levels with Gross Tumor Volume and Composition of Lymphocyte Subpopulations in Patients with Squamous Cell and Adeno Non-Small Cell Lung Cancer.A multifactoral analysis of 1452 patients for smoking sensation. An outpatient lab experience.Efficacy and safety of nivolumab in Japanese patients with advanced or recurrent squamous non-small cell lung cancer.Clinical features and treatment outcome of non-small cell lung cancer (NSCLC) patients with uncommon or complex epidermal growth factor receptor (EGFR) mutations.ATS Core Curriculum 2014: part I. Adult pulmonary medicine.Relative influence of c-Kit expression and epidermal growth factor receptor gene amplification on survival in patients with non-small cell lung cancer.Revisions to the Tumor, Node, Metastasis staging of lung cancer (8th edition): Rationale, radiologic findings and clinical implications.Correlation of EGFR expression, gene copy number and clinicopathological status in NSCLC.CT-based radiomic signature predicts distant metastasis in lung adenocarcinomaCCR9/CCL25 expression in non-small cell lung cancer correlates with aggressive disease and mediates key steps of metastasisTemporal trends in demographics and overall survival of non-small-cell lung cancer patients at Moffitt Cancer Center from 1986 to 2008.Astrocyte elevated gene-1(AEG-1) induces epithelial-mesenchymal transition in lung cancer through activating Wnt/β-catenin signalingExpression of CC chemokine receptor 9 predicts poor prognosis in patients with lung adenocarcinoma.Improved diagnostics targeting c-MET in non-small cell lung cancer: expression, amplification and activation?TNM staging update for lung cancer: Why is this important?Predicting the prognosis of lung cancer: the evolution of tumor, node and metastasis in the molecular age-challenges and opportunitiesSemiquantitative Computed Tomography Characteristics for Lung Adenocarcinoma and Their Association With Lung Cancer Survival.Endobronchial ultrasound-guided transbronchial needle aspiration in the staging of lung cancer patientsPatient outcomes of monotherapy with hypofractionated three-dimensional conformal radiation therapy for stage T2 or T3 non-small cell lung cancer: a retrospective study.Roles of osteopontin and matrix metalloproteinase-7 in occurrence, progression, and prognosis of nonsmall cell lung cancer.CT Features Associated with Epidermal Growth Factor Receptor Mutation Status in Patients with Lung Adenocarcinoma.Deriving stage at diagnosis from multiple population-based sources: colorectal and lung cancer in England.TNFRSF10B polymorphisms and haplotypes associated with increased risk of death in non-small cell lung cancer.Monocytic myeloid-derived suppressor cells as a potent suppressor of tumor immunity in non-small cell lung cancer.Progress in the management of limited-stage small cell lung cancer.Therapeutic non-toxic doses of TNF induce significant regression in TNFR2-p75 knockdown Lewis lung carcinoma tumor implants.Hidden treasures in "ancient" microarrays: gene-expression portrays biology and potential resistance pathways of major lung cancer subtypes and normal tissue.Beyond disease-progression: Clinical outcomes after EGFR-TKIs in a cohort of EGFR mutated NSCLC patients.Defining the biological basis of radiomic phenotypes in lung cancer.Prognostic value of Transglutaminase 2 in non-small cell lung cancer patients.Effects of long noncoding RNA SPRY4-IT1-mediated EZH2 on the invasion and migration of lung adenocarcinoma.The clinicopathological significance of hMLH1 hypermethylation in non-small-cell lung cancer: a meta-analysis and literature review.Systematic evaluation of lung tumor motion using four-dimensional computed tomography.miRNA profiling in serum and tissue samples to assess noninvasive biomarkers for NSCLC clinical outcome.Prophylactic cranial irradiation after definitive chemoradiotherapy for limited-stage small cell lung cancer: Do all patients benefit?Clinical and CT characteristics of surgically resected lung adenocarcinomas harboring ALK rearrangements or EGFR mutations.
P2860
Q26801595-BFCCF3F7-FBCE-4B49-B0C0-FA44C3E754C4Q27687836-D5555786-5953-4763-AB0B-2E4E9C9663B3Q28552102-B661FB47-D6DF-4CB0-ACBB-921F0C13052AQ30244613-A66A9991-49C6-4F5B-97D2-98A2814E50B2Q30315956-FC40BE50-4563-4448-8E97-7AAF122FEEA4Q33634980-7189079B-DB2B-4287-A13E-D4D3DBBED90EQ33738921-C7BAA116-CA71-4574-BF93-28BE97488D7BQ33779181-52E59578-6D16-4109-8F95-CDBACD41A3B6Q33786162-C77150B3-7A4F-44FE-9A0B-ADA94FC9B94EQ33843815-2F294FE8-5607-4E61-9A07-A7BC6E69D8C0Q33854852-04136513-9BE4-4F5F-8846-4A5D4608FC45Q34252140-14172AAE-C9F4-4E16-8BCC-893BFB81EC86Q34466023-EC52281B-E7CE-495E-9816-BD80158789C4Q34654463-D392C972-A0F8-4799-AD73-BD8F8000262EQ35125003-9D046804-1198-4EA6-A56A-422F5E9DDFFBQ35174883-D1F18D03-B65F-4A70-8FCE-1739CAE368D9Q35848297-6BAAA6E2-39A3-44B0-B2FE-A69466D6615CQ35896530-5E3D3E3E-3875-46D8-9242-79D91F9954F5Q35957881-597C5B27-33E3-476C-9F47-B57322F8DB71Q35996028-55B8F47B-D75A-42D1-9D96-64E230ADAE5EQ36173616-6FC63587-1477-47D1-BFFE-FC2B394EC982Q36372264-E0F2F48F-EAA5-4C8B-8CD6-73AFC0F084A3Q36476212-131EAAA0-E652-4C90-A688-42F7A65DCAC8Q36616806-6C8A394F-2D5D-4259-95CC-DB632E3C842CQ37069258-AA5CFDB5-1156-4F9F-AD38-79876B3135D4Q37151069-263F1D0E-7C9F-4E93-9940-BB19AEA87578Q37262175-379310B2-5D77-4931-B976-0D374B3727E9Q37581919-913695D4-D7C0-4A04-A47B-BCD71284EC32Q37626969-404B6508-ECC4-422D-BC5A-D39DD9B229D3Q38445760-F2D2BA6D-162B-40D8-BB65-5F6457DA14D2Q38471484-5CBCC54D-76BB-4F31-8AA7-886BCE7CD318Q38640618-C92B9562-AF43-42CE-BCE8-BB80C40E9523Q38668238-794E8EE2-100C-4458-9A30-F0906C7EF4D9Q38675384-3EA4330A-02F1-4916-B492-42670DA4BB9FQ38695240-06581FE7-C9A1-46FD-AF2C-D447EDD0C495Q38940735-C22BF140-A32A-4385-A634-D33673E52934Q39027522-CC577A5C-38EF-4F55-BFD2-2AB8908CE15AQ40323342-EB4D28D6-502D-4273-9B37-487E147DFBF6Q40386962-ED00CD2B-76A7-499D-BE35-35214E26064DQ40518308-7F0EABD1-959F-474E-8657-ECAF2A3AC48C
P2860
The 7th lung cancer TNM classification and staging system: Review of the changes and implications.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
The 7th lung cancer TNM classi ...... the changes and implications.
@ast
The 7th lung cancer TNM classi ...... the changes and implications.
@en
type
label
The 7th lung cancer TNM classi ...... the changes and implications.
@ast
The 7th lung cancer TNM classi ...... the changes and implications.
@en
prefLabel
The 7th lung cancer TNM classi ...... the changes and implications.
@ast
The 7th lung cancer TNM classi ...... the changes and implications.
@en
P2093
P2860
P356
P1476
The 7th lung cancer TNM classi ...... the changes and implications.
@en
P2093
Andrea Caulo
Dilip Oswal
Edwin van Beek
Saeed Mirsadraee
Yalda Alizadeh
P2860
P304
P356
10.4329/WJR.V4.I4.128
P577
2012-04-01T00:00:00Z